Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
J Oral Biosci ; 65(4): 356-364, 2023 12.
Article in English | MEDLINE | ID: mdl-37838226

ABSTRACT

OBJECTIVE: This study aimed to clarify the interactions between the tongue and primary afferent fibers in tongue cancer pain. METHODS: A pharmacological analysis was conducted to evaluate mechanical hypersensitivity of the tongues of rats with squamous cell carcinoma (SCC). Changes in trigeminal ganglion (TG) neurons projecting to the tongue were analyzed using immunohistochemistry and western blotting. RESULTS: SCC inoculation of the tongue caused persistent mechanical sensitization and tumor formation. Trypsin expression was significantly upregulated in cancer lesions. Continuous trypsin inhibition or protease-activated receptor 2 (PAR2) antagonism in the tongue significantly inhibited SCC-induced mechanical sensitization. No changes were observed in PAR2 and transient receptor potential vanilloid 4 (TRPV4) levels in the TG or the number of PAR2-and TRPV4-expressing TG neurons after SCC inoculation. In contrast, the relative amount of phosphorylated TRPV4 in the TG was significantly increased after SCC inoculation and abrogated by PAR2 antagonism in the tongue. TRPV4 antagonism in the tongue significantly ameliorated the mechanical sensitization caused by SCC inoculation. CONCLUSIONS: Our findings indicate that tumor-derived trypsin sensitizes primary afferent fibers by PAR2 stimulation and subsequent TRPV4 phosphorylation, resulting in severe tongue pain.


Subject(s)
Cancer Pain , Carcinoma, Squamous Cell , Glossalgia , Tongue Neoplasms , Animals , Rats , Cancer Pain/metabolism , Glossalgia/metabolism , Pain/metabolism , Phosphorylation , Receptor, PAR-2/metabolism , Tongue/metabolism , Tongue Neoplasms/metabolism , Trigeminal Nerve/metabolism , TRPV Cation Channels/metabolism , Trypsin/metabolism , Trypsin/pharmacology
2.
Neuroscience ; 519: 60-72, 2023 05 21.
Article in English | MEDLINE | ID: mdl-36958596

ABSTRACT

Neonatal pain experiences including traumatic injury influence negatively on development of nociceptive circuits, resulting in persistent pain hypersensitivity in adults. However, the detailed mechanism is not yet well understood. In the present study, to clarify the pathogenesis of orofacial pain hypersensitivity associated with neonatal injury, the involvement of the voltage-gated sodium channel (Nav) 1.8 and the C-C chemokine ligand 2 (CCL2)/C-C chemokine receptor 2 (CCR2) signaling in the trigeminal ganglion (TG) in facial skin incisional pain hypersensitivity was examined in 190 neonatal facial-injured and sham male rats. The whisker pad skin was incised on postnatal day 4 and week 7 (Incision-Incision group). Compared to the group without neonatal incision (Sham-Incision group), mechanical hypersensitivity in the whisker pad skin was enhanced in Incision-Incision group. The number of Nav1.8-immunoreactive TG neurons and the amount of CCL2 expressed in the macrophages and satellite glial cells in the TG were increased on day 14 after re-incision in the Incision-Incision group, compared with Sham-Incision group. Blockages of Nav1.8 in the incised region and CCR2 in the TG suppressed the enhancement of mechanical hypersensitivity in the Incision-Incision group. Administration of CCL2 into the TG enhanced mechanical hypersensitivity in the Sham-Sham, Incision-Sham and Sham-Incision group. Our results suggest that neonatal facial injury accelerates the TG neuronal hyperexcitability following orofacial skin injury in adult in association with Nav1.8 overexpression via CCL2 signaling, resulting in the enhancement of orofacial incisional pain hypersensitivity in the adulthood.


Subject(s)
Hyperalgesia , Surgical Wound , Rats , Male , Animals , Hyperalgesia/etiology , Rats, Sprague-Dawley , Pain Threshold , Facial Pain/pathology , Skin , Surgical Wound/complications , Trigeminal Ganglion
3.
J Oral Sci ; 65(2): 90-95, 2023 Mar 30.
Article in English | MEDLINE | ID: mdl-36792149

ABSTRACT

PURPOSE: The purpose of this study was to conduct basic research on the possibility of using cartilage tissue for hard-tissue reconstruction and to observe morphological changes in the transition of the cartilage to bone. METHODS: A 4-mm diameter bone defect was created in the right mandibular angle of rats. Cartilage, autologous bone, and artificial bone were grafted into the defect. Computed tomography (CT) was performed to measure the increase in bone volume. Further histological evaluation of the grafted site was performed. RESULTS: At 12 weeks, CT show that bone formation in the costal cartilage group was comparable to that in the autogenous bone group. Histologically, in the artificial bone group, a clear boundary was observed between the existing bone and defect, whereas in the costal cartilage and autologous bone groups, laminar plate bone repair of the defect was observed. CONCLUSION: The findings in this study suggest that bone reconstruction achieved with cartilage grafting is almost equivalent to that with autogenous bone grafting and that bone reconstruction using cartilage is clinically feasible. In future, if regenerated cartilage is successfully applied clinically, bone reconstruction using regenerated cartilage may be feasible.


Subject(s)
Costal Cartilage , Plastic Surgery Procedures , Animals , Rats , Costal Cartilage/transplantation , Tomography, X-Ray Computed , Mandible , Bone Regeneration , Transplantation, Autologous
4.
Int J Mol Sci ; 22(21)2021 Oct 22.
Article in English | MEDLINE | ID: mdl-34768835

ABSTRACT

Pain is one of the most severe concerns in tongue cancer patients. However, the underlying mechanisms of tongue cancer pain are not fully understood. We investigated the molecular mechanisms of tongue cancer-induced mechanical allodynia in the tongue by squamous cell carcinoma (SCC) inoculation in rats. The head-withdrawal threshold of mechanical stimulation (MHWT) to the tongue was reduced following SCC inoculation, which was inhibited by intracisternal administration of 10Panx, an inhibitory peptide for pannexin 1 (PANX1) channels. Immunohistochemical analyses revealed that the expression of PANX1 was upregulated in the trigeminal spinal subnucleus caudalis (Vc) following SCC inoculation. The majority of PANX1 immunofluorescence was merged with ionized calcium-binding adapter molecule 1 (Iba1) fluorescence and a part of it was merged with glial fibrillary acidic protein (GFAP) fluorescence. Spike frequencies of Vc nociceptive neurons to noxious mechanical stimulation were significantly enhanced in SCC-inoculated rats, which was suppressed by intracisternal 10Panx administration. Phosphorylated extracellular signal-regulated kinase (pERK)-immunoreactive (IR) neurons increased significantly in the Vc after SCC inoculation, which was inhibited by intracisternal 10Panx administration. SCC inoculation-induced MHWT reduction and increased pERK-IR Vc neuron numbers were inhibited by P2X7 purinoceptor (P2X7R) antagonism. Conversely, these effects were observed in the presence of P2X7R agonist in SCC-inoculated rats with PANX1 inhibition. SCC inoculation-induced MHWT reduction was significantly recovered by intracisternal interleukin-1 receptor antagonist administration. These observations suggest that SCC inoculation causes PANX1 upregulation in Vc microglia and adenosine triphosphate released through PANX1 sensitizes nociceptive neurons in the Vc, resulting in tongue cancer pain.


Subject(s)
Connexins/metabolism , Hyperalgesia/metabolism , Nerve Tissue Proteins/metabolism , Tongue Neoplasms/metabolism , Adenosine Triphosphate/metabolism , Animals , Cancer Pain/pathology , Carcinoma, Squamous Cell , Connexins/antagonists & inhibitors , Connexins/physiology , Extracellular Signal-Regulated MAP Kinases/metabolism , Hyperalgesia/physiopathology , Male , Microglia/metabolism , Nerve Tissue Proteins/antagonists & inhibitors , Nerve Tissue Proteins/physiology , Neurons/metabolism , Nociceptors/metabolism , Pain/metabolism , Pain/physiopathology , Pain Measurement , Pain Threshold/drug effects , Rats , Rats, Inbred F344 , Signal Transduction , Tongue/metabolism , Tongue/pathology , Tongue Neoplasms/physiopathology , Trigeminal Nucleus, Spinal/metabolism , Trigeminal Nucleus, Spinal/physiopathology
5.
Neuroscience ; 468: 43-52, 2021 08 01.
Article in English | MEDLINE | ID: mdl-34102263

ABSTRACT

Sensory disturbance in the orofacial region owing to trigeminal nerve injury is caused by dental treatment or accident. Commercially available therapeutics are ineffective for the treatment of sensory disturbance. Additionally, the therapeutic effects of rapamycin, an allosteric inhibitor of mammalian target of rapamycin (mTOR), which negatively regulates autophagy, on the sensory disturbance are not fully investigated. Thus, we investigated the therapeutic effects of rapamycin on the sensory disturbance in the mandibular region caused by inferior alveolar nerve (IAN) transection (IANX) in rats. The expression levels of the phosphorylated p70S6K, a downstream molecule of mTOR, in the proximal and distal stumps of the transected IAN were significantly reduced by rapamycin administration to the injured site. Conversely, the increments of both Beclin 1 and microtubule-associated protein-1 light chain 3-II protein levels in the proximal and distal stumps of the transected IAN was induced by rapamycin administration. Immunohistochemical analyses revealed that Beclin 1 was located in Schwann cells in the proximal stump of the IAN. Accumulation of myelin protein zero and myelin basic protein in the proximal and distal stumps of the IAN was significantly reduced by rapamycin administration. Rapamycin administration facilitated axon regeneration after IANX and increased the number of brain-derived neurotrophic factor positive neurons in the trigeminal ganglion. Thus, recovery from sensory disturbance in the lower lip caused by IANX was markedly facilitated by rapamycin. These findings suggest that rapamycin administration is a promising treatment for the sensory disturbance caused by IANX.


Subject(s)
Sirolimus , Trigeminal Nerve Injuries , Animals , Autophagy , Axons , Mandibular Nerve , Nerve Regeneration , Rats , Rats, Sprague-Dawley , Schwann Cells , Sirolimus/pharmacology , Trigeminal Nerve Injuries/drug therapy
6.
J Headache Pain ; 22(1): 31, 2021 Apr 26.
Article in English | MEDLINE | ID: mdl-33902429

ABSTRACT

BACKGROUND: Trigeminal neuralgia is a characteristic disease that manifests as orofacial phasic or continuous severe pain triggered by innocuous orofacial stimulation; its mechanisms are not fully understood. In this study, we established a new animal model of trigeminal neuralgia and investigated the role of P2X3 receptor (P2X3R) alteration in the trigeminal ganglion (TG) via tumor necrosis factor alpha (TNFα) signaling in persistent orofacial pain. METHODS: Trigeminal nerve root compression (TNC) was performed in male Sprague-Dawley rats. Changes in the mechanical sensitivity of whisker pad skin, amount of TNFα in the TG, and number of P2X3R and TNF receptor-2 (TNFR2)-positive TG neurons were assessed following TNC. The effects of TNFR2 antagonism in TG and subcutaneous P2X3R antagonism on mechanical hypersensitivity following TNC were examined. RESULTS: TNC induced unilateral continuous orofacial mechanical allodynia, which was depressed by carbamazepine. The accumulation of macrophages showing amoeboid-like morphological changes and expression of TNFα in the TG was remarkably increased following TNC treatment. The number of P2X3R- and TNFR2-positive TG neurons innervating the orofacial skin was significantly increased following TNC. TNFα was released from activated macrophages that occurred in the TG following TNC, and TNFR2 antagonism in the TG significantly diminished the TNC-induced increase in P2X3R-immunoreactive TG neurons. Moreover, subcutaneous P2X3R antagonism in the whisker pad skin significantly depressed TNC-induced mechanical allodynia. CONCLUSIONS: Therefore, it can be concluded that the signaling of TNFα released from activated macrophages in the TG induces the upregulation of P2X3R expression in TG neurons innervating the orofacial region, resulting in orofacial mechanical allodynia following TNC.


Subject(s)
Neuralgia , Trigeminal Neuralgia , Animals , Facial Pain , Hyperalgesia , Macrophages , Male , Neurons , Rats , Rats, Sprague-Dawley , Trigeminal Ganglion , Tumor Necrosis Factor-alpha , Up-Regulation
7.
Int J Mol Sci ; 21(23)2020 Dec 01.
Article in English | MEDLINE | ID: mdl-33271955

ABSTRACT

We evaluated the mechanisms underlying the oxytocin (OXT)-induced analgesic effect on orofacial neuropathic pain following infraorbital nerve injury (IONI). IONI was established through tight ligation of one-third of the infraorbital nerve thickness. Subsequently, the head withdrawal threshold for mechanical stimulation (MHWT) of the whisker pad skin was measured using a von Frey filament. Trigeminal ganglion (TG) neurons innervating the whisker pad skin were identified using a retrograde labeling technique. OXT receptor-immunoreactive (IR), transient receptor potential vanilloid 1 (TRPV1)-IR, and TRPV4-IR TG neurons innervating the whisker pad skin were examined on post-IONI day 5. The MHWT remarkably decreased from post-IONI day 1 onward. OXT application to the nerve-injured site attenuated the decrease in MHWT from day 5 onward. TRPV1 or TRPV4 antagonism significantly suppressed the decrement of MHWT following IONI. OXT receptors were expressed in the uninjured and Fluoro-Gold (FG)-labeled TG neurons. Furthermore, there was an increase in the number of FG-labeled TRPV1-IR and TRPV4-IR TG neurons, which was inhibited by administering OXT. This inhibition was suppressed by co-administration with an OXT receptor antagonist. These findings suggest that OXT application inhibits the increase in TRPV1-IR and TRPV4-IR TG neurons innervating the whisker pad skin, which attenuates post-IONI orofacial mechanical allodynia.


Subject(s)
Cranial Nerve Injuries/complications , Facial Neuralgia/etiology , Facial Neuralgia/metabolism , Neurons/metabolism , Oxytocin/administration & dosage , Transient Receptor Potential Channels/genetics , Trigeminal Ganglion/metabolism , Animals , Disease Models, Animal , Facial Neuralgia/diagnosis , Fluorescent Antibody Technique , Gene Expression Regulation/drug effects , Pain Threshold/drug effects , Rats , Receptors, Oxytocin/genetics , Receptors, Oxytocin/metabolism , Transient Receptor Potential Channels/metabolism
8.
Int J Mol Sci ; 20(24)2019 Dec 17.
Article in English | MEDLINE | ID: mdl-31861182

ABSTRACT

Insulin-like growth factor-1 (IGF-1) is upregulated in the injured peripheral nerve bundle and controls nociceptive neuronal excitability associated with peripheral nerve injury. Here, we examined the involvement of IGF-1 signaling in orofacial neuropathic pain following infraorbital nerve injury (IONI) in rats. IONI promoted macrophage accumulation in the injured ION, as well as in the ipsilateral trigeminal ganglion (TG), and induced mechanical allodynia of the whisker pad skin together with the enhancement of neuronal activities in the subnucleus caudalis of the spinal trigeminal nucleus and in the upper cervical spinal cord. The levels of IGF-1 released by infiltrating macrophages into the injured ION and the TG were significantly increased. The IONI-induced the number of transient receptor potential vanilloid (TRPV) subfamily type 4 (TRPV4) upregulation in TRPV subfamily type 2 (TRPV2)-positive small-sized, and medium-sized TG neurons were inhibited by peripheral TRPV2 antagonism. Furthermore, the IONI-induced mechanical allodynia was suppressed by TRPV4 antagonism in the whisker pad skin. These results suggest that IGF-1 released by macrophages accumulating in the injured ION binds to TRPV2, which increases TRPV4 expression in TG neurons innervating the whisker pad skin, ultimately resulting in mechanical allodynia of the whisker pad skin.


Subject(s)
Facial Pain/metabolism , Hyperalgesia/metabolism , Insulin-Like Growth Factor I/metabolism , Neuralgia/metabolism , Trigeminal Nerve Injuries/metabolism , Animals , Facial Pain/physiopathology , Hyperalgesia/physiopathology , Macrophages/metabolism , Male , Neuralgia/physiopathology , Neurons/metabolism , Pain Threshold , Rats, Sprague-Dawley , Spinal Cord/metabolism , TRPV Cation Channels/metabolism , Trigeminal Ganglion , Trigeminal Nerve Injuries/physiopathology , Vibrissae/innervation , Vibrissae/metabolism
9.
Anesthesiology ; 128(6): 1207-1219, 2018 06.
Article in English | MEDLINE | ID: mdl-29461271

ABSTRACT

BACKGROUND: Patients with early stage tongue cancer do not frequently complain of tongue pain. Endothelin-1 signaling is upregulated in the cancerous tongue at the early stage. We tested the hypothesis that endothelin-1 signaling contributes to the modulation of tongue nociception. METHODS: Squamous cell carcinoma cells were inoculated into the tongue under general anesthesia. Lingual mechanical sensitivity under light anesthesia using forceps from days 1 to 21 (n = 8) and the amounts of endothelin-1 and ß-endorphin in the tongue on days 6, 14, and 21 (n = 5 to 7) were examined after the inoculation. The effect of endothelin-A or µ-opioid receptor antagonism on the mechanical sensitivity was examined (n = 5 to 7). RESULTS: Lingual mechanical sensitivity did not change at the early stage (days 5 to 6) but increased at the late stage (days 13 to 14). The amount of endothelin-1 increased (25.4 ± 4.8 pg/ml vs. 15.0 ± 5.2 pg/ml; P = 0.008), and endothelin-A receptor antagonism in the tongue induced mechanical hypersensitivity at the early stage (51 ± 9 g vs. 81 ± 6 g; P = 0.0001). The µ-opioid receptor antagonism enhanced mechanical hypersensitivity (39 ± 7 g vs. 81 ± 6 g; P < 0.0001), and the amount of ß-endorphin increased at the early stage. CONCLUSIONS: ß-Endorphin released from the cancer cells via endothelin-1 signaling is involved in analgesic action in mechanical hypersensitivity at the early stage.


Subject(s)
Carcinoma, Squamous Cell/metabolism , Endothelin-1/metabolism , Nociception/physiology , Signal Transduction/physiology , Tongue Neoplasms/metabolism , Animals , Carcinoma, Squamous Cell/pathology , Male , Narcotic Antagonists/pharmacology , Neoplasm Staging/methods , Nociception/drug effects , Rats , Rats, Inbred F344 , Receptors, Opioid, mu/antagonists & inhibitors , Receptors, Opioid, mu/physiology , Signal Transduction/drug effects , Tongue Neoplasms/pathology
10.
J Neuroinflammation ; 14(1): 249, 2017 Dec 16.
Article in English | MEDLINE | ID: mdl-29246259

ABSTRACT

BACKGROUND: Accidental mandibular nerve injury may occur during tooth extraction or implant procedures, causing ectopic orofacial pain. The exact mechanisms underlying ectopic orofacial pain following mandibular nerve injury is still unknown. Here, we investigated the role of macrophages and tumor necrosis factor alpha (TNFα) in the trigeminal ganglion (TG) in ectopic orofacial pain following inferior alveolar nerve transection (IANX). METHODS: IANX was performed and the mechanical head-withdrawal threshold (MHWT) in the whisker pad skin ipsilateral to IANX was measured for 15 days. Expression of Iba1 in the TG was examined on day 3 after IANX, and the MHWT in the whisker pad skin ipsilateral to IANX was measured following successive intra-ganglion administration of the macrophage depletion agent liposomal clodronate Clophosome-A (LCCA). TNFα expression in the TG and the MHWT in the whisker pad skin ipsilateral to IANX following successive intra-ganglion administration of the TNFα blocker etanercept were measured on day 3 after IANX, and tumor necrosis factor receptor-1 (TNFR1) immunoreactive (IR) cells in the TG were analyzed immunohistochemically on day 3. RESULTS: The MHWT in the whisker pad skin was significantly decreased for 15 days, and the number of Iba1-IR cells was significantly increased in the TG on day 3 after IANX. Successive intra-ganglion administration of the macrophage depletion agent LCCA significantly reduced the increased number of Iba1-IR cells in the TG and reversed the IANX-induced decrease in MHWT in the whisker pad skin. TNFα expression was increased in the TG on day 3 after IANX and was reduced following successive intra-ganglion administration of the TNFα inhibitor etanercept. The decreased MHWT was also recovered by etanercept administration, and TNFR1-IR cells in the TG were increased on day 3 following IANX. CONCLUSIONS: These findings suggest that signaling cascades resulting from the production of TNFα by infiltrated macrophages in the TG contributes to the development of ectopic mechanical allodynia in whisker pad skin following IANX.


Subject(s)
Facial Pain/immunology , Hyperalgesia/immunology , Macrophages/immunology , Trigeminal Ganglion/immunology , Trigeminal Nerve Injuries/immunology , Animals , Facial Pain/etiology , Male , Mandibular Nerve , Neuralgia/immunology , Physical Stimulation , Rats , Rats, Sprague-Dawley , Trigeminal Nerve Injuries/complications , Tumor Necrosis Factor-alpha/biosynthesis
11.
Pain ; 158(9): 1754-1764, 2017 Sep.
Article in English | MEDLINE | ID: mdl-28621704

ABSTRACT

Peripheral tissue inflammation or injury causes glutamate release from nociceptive axons, keratinocytes, and Schwann cells, resulting in thermal hypersensitivity. However, the detailed molecular mechanisms underlying glutamate-induced thermal hypersensitivity are unknown. The aim of this study was to clarify the involvement of peripheral transient receptor potential (TRP) TRP vanilloid 1 (TRPV1), TRP ankyrin 1 (TRPA1), and protein kinase C epsilon (PKCε) in glutamate-induced pain hypersensitivity. The amount of glutamate in the facial tissue was significantly increased 3 days after facial Complete Freund's adjuvant injection. The head-withdrawal reflex threshold to heat, cold, or mechanical stimulation was significantly decreased on day 7 after continuous glutamate or metabotropic glutamate receptor 5 (mGluR5) agonist (CHPG) injection into the facial skin compared with vehicle-injected rats, and glutamate-induced hypersensitivity was significantly recovered by mGluR5 antagonist MTEP, TRPA1 antagonist HC-030031, TRPV1 antagonist SB366791, or PKCε translocation inhibitor administration into the facial skin. TRPV1 and TRPA1 were expressed in mGluR5-immunoreactive (IR) trigeminal ganglion (TG) neurons innervating the facial skin, and mGluR5-IR TG neurons expressed PKCε. There was no significant difference in the number of GluR5-IR TG neurons among glutamate-injected, saline-injected, and naive rats, whereas that of TRPV1- or TRPA1-IR TG neurons was significantly increased 7 days after continuous glutamate injection into the facial skin compared with vehicle injection. PKCε phosphorylation in TG was significantly enhanced following glutamate injection into the facial skin. Moreover, neuronal activity of TG neurons was significantly increased following facial glutamate treatment. The present findings suggest that sensitization of TRPA1 and/or TRPV1 through mGluR5 signaling via PKCε is involved in facial thermal and mechanical hypersensitivity.


Subject(s)
Hyperalgesia/metabolism , Pain Threshold/physiology , Receptor, Metabotropic Glutamate 5/metabolism , Signal Transduction/physiology , TRPA1 Cation Channel/metabolism , TRPV Cation Channels/metabolism , Acetanilides/pharmacology , Animals , Disease Models, Animal , Enzyme Inhibitors/pharmacology , Freund's Adjuvant/toxicity , Glutamic Acid/metabolism , Glutamic Acid/toxicity , Glycine/analogs & derivatives , Glycine/pharmacology , Hyperalgesia/etiology , Male , Neurons/drug effects , Neurons/physiology , Pain/chemically induced , Pain/complications , Pain Threshold/drug effects , Phenylacetates/pharmacology , Physical Stimulation/adverse effects , Purines/pharmacology , Pyridines/pharmacology , Rats , Rats, Sprague-Dawley , Skin/innervation , TRPA1 Cation Channel/antagonists & inhibitors , TRPV Cation Channels/antagonists & inhibitors , Thiazoles/pharmacology , Trigeminal Ganglion/cytology
12.
Eur J Oral Sci ; 122(6): 391-6, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25371244

ABSTRACT

Orofacial cold hyperalgesia is known to cause severe persistent pain in the face following trigeminal nerve injury or inflammation, and transient receptor potential (TRP) vanilloid 1 (TRPV1) and TRP ankylin 1 (TRPA1) are thought to be involved in cold hyperalgesia. However, how these two receptors are involved in cold hyperalgesia is not fully understood. To clarify the mechanisms underlying facial cold hyperalgesia, nocifensive behaviors to cold stimulation, the expression of TRPV1 and TRPA1 in trigeminal ganglion (TG) neurons, and TG neuronal excitability to cold stimulation following facial capsaicin injection were examined in rats. The head-withdrawal reflex threshold (HWRT) to cold stimulation of the lateral facial skin was significantly decreased following facial capsaicin injection. This reduction of HWRT was significantly recovered following local injection of TRPV1 antagonist as well as TRPA1 antagonist. Approximately 30% of TG neurons innervating the lateral facial skin expressed both TRPV1 and TRPA1, and about 64% of TRPA1-positive neurons also expressed TRPV1. The TG neuronal excitability to noxious cold stimulation was significantly increased following facial capsaicin injection and this increase was recovered by pretreatment with TRPA1 antagonist. These findings suggest that TRPA1 sensitization via TRPV1 signaling in TG neurons is involved in cold hyperalgesia following facial skin capsaicin injection.


Subject(s)
Capsaicin/adverse effects , Cold Temperature/adverse effects , Facial Pain/etiology , Hyperalgesia/etiology , Sensory System Agents/adverse effects , TRPC Cation Channels/physiology , Acetanilides/pharmacology , Anilides/pharmacology , Animals , Behavior, Animal , Capsaicin/pharmacology , Cinnamates/pharmacology , Electromyography/instrumentation , Face , Hot Temperature/adverse effects , Injections, Intradermal , Male , Neural Conduction/drug effects , Neural Conduction/physiology , Neurons/chemistry , Neurons/drug effects , Physical Stimulation , Purines/pharmacology , Rats , Rats, Sprague-Dawley , Reflex/drug effects , Reflex/physiology , Sensory System Agents/pharmacology , Synaptic Transmission/drug effects , Synaptic Transmission/physiology , TRPA1 Cation Channel , TRPC Cation Channels/analysis , TRPC Cation Channels/antagonists & inhibitors , TRPV Cation Channels/analysis , TRPV Cation Channels/antagonists & inhibitors , TRPV Cation Channels/physiology , Trigeminal Ganglion/chemistry , Trigeminal Ganglion/drug effects
13.
J Neuroinflammation ; 9: 258, 2012 Nov 27.
Article in English | MEDLINE | ID: mdl-23181395

ABSTRACT

BACKGROUND: In the orofacial region, limited information is available concerning pathological tongue pain, such as inflammatory pain or neuropathic pain occurring in the tongue. Here, we tried for the first time to establish a novel animal model of inflammatory tongue pain in rats and to investigate the roles of metabotropic glutamate receptor 5 (mGluR5)-extracellular signal-regulated kinase (ERK) signaling in this process. METHODS: Complete Freund's adjuvant (CFA) was submucosally injected into the tongue to induce the inflammatory pain phenotype that was confirmed by behavioral testing. Expression of phosphorylated ERK (pERK) and mGluR5 in the trigeminal subnucleus caudalis (Vc) and upper cervical spinal cord (C1-C2) were detected with immunohistochemical staining and Western blotting. pERK inhibitor, a selective mGluR5 antagonist or agonist was continuously administered for 7 days via an intrathecal (i.t.) route. Local inflammatory responses were verified by tongue histology. RESULTS: Submucosal injection of CFA into the tongue produced a long-lasting mechanical allodynia and heat hyperalgesia at the inflamed site, concomitant with an increase in the pERK immunoreactivity in the Vc and C1-C2. The distribution of pERK-IR cells was laminar specific, ipsilaterally dominant, somatotopically relevant, and rostrocaudally restricted. Western blot analysis also showed an enhanced activation of ERK in the Vc and C1-C2 following CFA injection. Continuous i.t. administration of the pERK inhibitor and a selective mGluR5 antagonist significantly depressed the mechanical allodynia and heat hyperalgesia in the CFA-injected tongue. In addition, the number of pERK-IR cells in ipsilateral Vc and C1-C2 was also decreased by both drugs. Moreover, continuous i.t. administration of a selective mGluR5 agonist induced mechanical allodynia in naive rats. CONCLUSIONS: The present study constructed a new animal model of inflammatory tongue pain in rodents, and demonstrated pivotal roles of the mGluR5-pERK signaling in the development of mechanical and heat hypersensitivity that evolved in the inflamed tongue. This tongue-inflamed model might be useful for future studies to further elucidate molecular and cellular mechanisms of pathological tongue pain such as burning mouth syndrome.


Subject(s)
Extracellular Signal-Regulated MAP Kinases/metabolism , Pain/pathology , Receptors, Metabotropic Glutamate/physiology , Signal Transduction/physiology , Spinal Cord/metabolism , Trigeminal Caudal Nucleus/metabolism , Analysis of Variance , Animals , Disease Models, Animal , Electromyography , Enzyme Inhibitors/pharmacology , Excitatory Amino Acid Agonists/pharmacology , Excitatory Amino Acid Antagonists/pharmacology , Flavonoids/pharmacology , Freund's Adjuvant/adverse effects , Functional Laterality , Glossitis/chemically induced , Glossitis/complications , Glycine/analogs & derivatives , Glycine/pharmacology , Hyperalgesia/physiopathology , Male , Pain/etiology , Pain Measurement , Pain Threshold/drug effects , Phenylacetates/pharmacology , Phosphorylation/drug effects , Rats , Rats, Sprague-Dawley , Reaction Time/drug effects , Receptor, Metabotropic Glutamate 5 , Sacrococcygeal Region/pathology , Signal Transduction/drug effects , Tongue/pathology
14.
J Neurochem ; 83(2): 381-9, 2002 Oct.
Article in English | MEDLINE | ID: mdl-12423248

ABSTRACT

In this study, the internalization mechanism of basic fibroblast growth factor (bFGF) at the blood-brain barrier (BBB) was investigated using a conditionally immortalized mouse brain capillary endothelial cell line (TM-BBB4 cells) as an in vitro model of the BBB and the corresponding receptor was identified using immunohistochemical analysis. The heparin-resistant binding of [125I]bFGF to TM-BBB4 cells was found to be time-, temperature-, osmolarity- and concentration-dependent. Kinetic analysis of the cell-surface binding of [125I]bFGF to TM-BBB4 cells revealed saturable binding with a half-saturation constant of 76 +/- 24 nm and a maximal binding capacity of 183 +/- 17 pmol/mg protein. The heparin-resistant binding of [125I]bFGF to TM-BBB4 was significantly inhibited by a cationic polypeptide poly-L-lysine (300 micro m), and compounds which contain a sulfate moiety, e.g. heparin and chondroitin sulfate-B (each 10 micro g/mL). Moreover, the heparin-resistant binding of [125I]bFGF in TM-BBB4 cells was significantly reduced by 50% following treatment with sodium chlorate, suggesting the loss of perlecan (a core protein of heparan sulfate proteoglycan, HSPG) from the extracellular matrix of the cells. This type of binding is consistent with the involvement HSPG-mediated endocytosis. RT-PCR analysis revealed that HSPG mRNA and FGFR1 and FGFR2 (tyrosine-kinase receptors for bFGF) mRNA are expressed in TM-BBB4 cells. Moreover, immunohistochemical analysis demonstrated that perlecan is expressed on the abluminal membrane of the mouse brain capillary. These results suggest that bFGF is internalized via HSPG, which is expressed on the abluminal membrane of the BBB. HSPG at the BBB may play a role in maintaining the BBB function due to acceptance of the bFGF secreted from astrocytes.


Subject(s)
Blood-Brain Barrier/physiology , Brain/metabolism , Endothelium, Vascular/metabolism , Fibroblast Growth Factor 2/metabolism , Heparan Sulfate Proteoglycans/metabolism , Animals , Binding, Competitive/drug effects , Binding, Competitive/physiology , Brain/blood supply , Brain/cytology , Capillaries/cytology , Cell Line , Endothelium, Vascular/cytology , Fibroblast Growth Factor 2/pharmacokinetics , Heparan Sulfate Proteoglycans/biosynthesis , Heparan Sulfate Proteoglycans/genetics , Immunohistochemistry , Ligands , Mice , RNA, Messenger/biosynthesis , Receptors, Fibroblast Growth Factor/biosynthesis , Receptors, Fibroblast Growth Factor/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...